Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loop vs Loop+Thiazide in Heart Failure
NCT03999216Phase 4Withdrawn
- Sponsor
- Stanford University
- Start
- Jul 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Stanford University. Primary endpoint: Hospital length of stay up to 90 days. Planned start Jul 2023; status: withdrawn.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03999216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999216.